Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2 - Wikidata - wikimedia - TriplyDB

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

http://www.wikidata.org/entity/Q34803113

about

Fish oil: what the prescriber needs to know Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndrome Hypoxia upregulates PGI-synthase and increases PGI₂ release in human vascular cells exposed to inflammatory stimuli Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors Hormones in Dairy Foods and Their Impact on Public Health - A Narrative Review Article Effect of non-selective, non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors on the PFA-100 closure time The safety of rofecoxib The cardiovascular toxicity of selective and nonselective cyclooxygenase inhibitors: comparisons, contrasts, and aspirin confounding Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs Genetic and pharmacological analysis of prostanoid receptor function Prostaglandins and cancer Lumiracoxib does not affect the ex vivo antiplatelet aggregation activity of low-dose aspirin in healthy subjects Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning Cardiovascular hazard of selective COX-2 inhibitors: myth or reality?Prostaglandin E2 release in gastric antral mucosa of guinea-pigs: basal PGE2 release by cyclo-oxygenase 2 and ACh-stimulated PGE2 release by cyclo-oxygenase 1 A novel electron paramagnetic resonance-based assay for prostaglandin H synthase-1 activity Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions Effects of selective cyclooxygenase isoform inhibition on systemic prostacyclin synthesis and on platelet function at rest and after exercise in healthy volunteers Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen Role of ETB and B2 receptors in the ex vivo platelet inhibitory properties of endothelin and bradykinin in the mouse Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge Chemoprevention of intestinal tumorigenesis by nabumetone: induction of apoptosis and Bcl-2 downregulation Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II Tetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats Effects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cells Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function Vascular COX-2 modulates blood pressure and thrombosis in mice.Oxytocin evokes a pulsatile PGE2 release from ileum mucosa and is required for repair of intestinal epithelium after injury.COX-2 inhibition: what we learned--a controversial update on safety data.Early vasodilator response to anodal current application in human is not impaired by cyclooxygenase-2 blockade.Low endotoxemia prevents the reduction of gastric blood flow induced by NSAIDs: role of nitric oxide.Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data.Phase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers.Microglial TNFα Induces COX2 and PGI2 Synthase Expression in Spinal Endothelial Cells during Neuropathic Pain.

P2860

Q21195667-88FDF505-F2FD-4B11-B6E8-E99C5F234664 Q24185813-AB25A059-4DC3-4144-BBEC-97B5220D6AB1 Q24339277-32B9173D-57F9-40D5-B11B-2E61784F91E7 Q24632466-64AB223F-A890-4B29-B6EF-9D00AD5BF6AC Q24675327-78578FCE-4B21-4E86-96A2-5E251AFCEE59 Q24796005-40704188-3419-465C-818E-C4C640021CC5 Q26799965-70948F6A-D84C-4E70-B2D5-F8D19E0F3E2B Q28171125-F6D24DF3-AA3C-4179-8947-06F33C1172A0 Q28176535-B610FFF7-B35C-43ED-800A-DB61F2815221 Q28177082-BC26EC1E-8941-4A2D-B55E-42A2CF6DE05B Q28186050-79D26F8E-8301-464C-866C-A2513A6BC35D Q28186062-B567D57A-6E7D-42FB-998A-B2D1BF1B0ECC Q28188827-A15BDC8E-7C0C-4A63-8412-7358A827D912 Q28192026-824929C3-9353-4791-807F-6ABC2BD21189 Q28192589-A4BDA6D8-29F3-4ACF-8F88-4B5310105AA7 Q28192716-1E6F4199-293C-4519-9E34-55FE3509AF34 Q28193545-866A8CA4-271D-45CA-8A9C-4CFBA5CC60B8 Q28198746-B420E87C-EEF7-478F-81C8-AF6E70F5E5B7 Q28200401-FAC8C8B5-E073-4528-A7DC-AC1A250906D6 Q28200568-BC0F311C-37BD-49BD-8847-C2979F4C030D Q28211940-4A4494B8-73B0-486D-AB48-A696F2E059FB Q28218884-F6664A0D-E66E-4E57-B19D-F693940905E1 Q28219483-267FD232-522C-413B-BA83-6C171401529E Q28344081-D1B429E5-2EAE-487E-94F0-7270C26A7CC3 Q28348645-6A730E31-4B7D-4F7B-B2EB-2BBC6BEF9DC5 Q28349952-243143F0-472A-4493-A7ED-636FA56958CF Q28361239-50042395-541E-4E5E-98A0-B3528523DFF5 Q28365285-75C47FB4-83C2-4ADA-ADD7-8050CA7E7E3A Q28508911-46978FC1-FD05-4420-A351-D0818585AA25 Q28565662-167A595D-8850-4424-9904-647894A7CA07 Q28571669-1CDCECB0-E5E1-4D92-902E-D4E2F21C13E9 Q30477135-DC9B7B7E-C4BF-4492-B216-EC36731C266E Q30562262-31126E35-1BE5-42C0-BC12-6E733138A9C0 Q30657395-AAD644F9-96A1-46CB-9153-45864A20476B Q30724476-E96172BF-8C8E-434F-B5FE-02A0202AC363 Q31131984-2895D159-D5A3-41E6-ACEE-BB5D94E968A4 Q31143606-AB3C507D-4AA6-4937-97E2-0073801D3F6A Q33533952-2B43EE1B-8759-4196-BEB9-B097A64836B2 Q33561179-672C6713-0647-4DCA-8420-9C3E95F02376 Q33588645-ED83A5FC-DD1B-40FD-94AA-8A807BF7C068

P2860

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

http://www.wikidata.org/entity/Q34803113

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Systemic biosynthesis of prost ...... a selective inhibitor of COX-2

@ast

Systemic biosynthesis of prost ...... a selective inhibitor of COX-2

@en

Systemic biosynthesis of prostacyclin by cyclooxygenase

@nl

type

label

Systemic biosynthesis of prost ...... a selective inhibitor of COX-2

@ast

Systemic biosynthesis of prost ...... a selective inhibitor of COX-2

@en

Systemic biosynthesis of prostacyclin by cyclooxygenase

@nl

prefLabel

Systemic biosynthesis of prost ...... a selective inhibitor of COX-2

@ast

Systemic biosynthesis of prost ...... a selective inhibitor of COX-2

@en

Systemic biosynthesis of prostacyclin by cyclooxygenase

@nl

P1433

Q34803113-F9A01B9F-F4B0-48C2-AEB7-E6F8F2960A39

P1476

Q34803113-5EBEFD0C-858A-4038-8523-938554528DC4

P2093

Q34803113-0EAA611D-7FA7-42C1-BA11-862A37047E8C

Q34803113-40D9E7E4-58BB-41DE-B603-C2F563BC408F

Q34803113-61315425-54C6-4639-81CB-859049CC359E

Q34803113-AB35116D-2CCD-48A3-93DA-6E3BEA3B9A13

Q34803113-B8730251-4194-475E-A1A6-C75A6590170C

Q34803113-C46EAE8E-7D7D-470F-A647-2B28F5273A01

P2860

Q34803113-03BB964A-854E-42E8-8CFA-CD3BB7FBB5CB

Q34803113-046775DB-1E11-40A7-BFA7-1160BC8D566C

Q34803113-0C4401E8-E531-4260-9C1C-26A33C2FF3BD

Q34803113-12B99611-65AC-4162-8DCD-FA1600E40AE2

Q34803113-12BDA2BC-29B4-4A17-A1DE-83599B6BCF5D

Q34803113-172E5B79-2EEB-4A8F-B694-5C7B946EB6E3

Q34803113-1C7D2C9D-440B-4231-B7AF-EE074C9B0AB4

Q34803113-1E297A8E-CD19-42AD-9375-411284337132

Q34803113-1E3CA370-6A52-4669-A8AF-B3D852814579

Q34803113-25F0B63B-0ED9-404F-948B-478E6C27B80B

P304

Q34803113-AF2214FC-84BA-4E7B-830C-ED989F82DF05

P31

Q34803113-F9B20711-2E69-4948-B9F4-81846772DAAC

P356

Q34803113-A468E35A-A47F-46B1-B2B0-25D2E71AEBC5

P407

Q34803113-4ADAD1F6-3DB7-4A68-AB29-09DF257A21EA

P433

Q34803113-1879CE0D-19BD-4CB6-861F-C2069D4E8CEA

P478

Q34803113-1C37E06A-0CFB-4852-929C-3957F1993736

P577

Q34803113-DF3379C1-AF6E-41E2-8C26-F03A8D914F8D

P5875

Q34803113-6C6ECE95-0C85-491F-A544-6DB3D400E591

P698

Q34803113-6F3D2EF2-BFBA-4659-BB4E-262DE847FDEA

P921

Q34803113-C8B8D7B1-729D-4903-83C4-2EE1A30C4399

P932

Q34803113-5A6CFBD1-F706-45A5-ABB8-376631155A60

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Systemic biosynthesis of prost ...... a selective inhibitor of COX-2

@en

P2093

B F McAdam

http://www.w3.org/2001/XMLSchema#string

F Catella-Lawson

http://www.w3.org/2001/XMLSchema#string

G A FitzGerald

http://www.w3.org/2001/XMLSchema#string

I A Mardini

http://www.w3.org/2001/XMLSchema#string

J A Lawson

http://www.w3.org/2001/XMLSchema#string

S Kapoor

http://www.w3.org/2001/XMLSchema#string

P2860

Human cyclooxygenase-2 cDNA

Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment

cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation

Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

P304

272-277

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.96.1.272

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13413264

http://www.w3.org/2001/XMLSchema#string

P698

9874808

http://www.w3.org/2001/XMLSchema#string

P921

P932

15129

http://www.w3.org/2001/XMLSchema#string